|
|
|
Home > In Vitro Diagnostics > Molecular Diagnostics > Competing in the US Molecular Diagnostics Market
|
Competing in the US Molecular Diagnostics Market
|
|
|
|
This new 1,157-page report from Venture Planning Group contains 65 tables, and presents a comprehensive analysis of the US molecular diagnostics market, including: - Major issues pertaining to the US molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
- An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods.
- Five-year test volume and reagent sales forecasts for the following categories:
- Infectious Diseases - Genetic Diseases - Cancer - Paternity Testing/HLA Typing - Forensic Testing
- Review of testing methodologies an instrumentation technologies.
- Feature comparison of automated and semiautomated analyzers.
- Sales and market shares of leading suppliers.
- Over 60 specific opportunities for molecular diagnostic instruments, test systems, IT and auxiliary products.
- Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.
- Business planning issues and concerns.
Contains 1,157 pages and 65 tables
|
|
|
|
|
|
|
|
|
|
Local PDF: $1750.00 Other Formats: Global PDF, DataPack
|
|
|
|
|
|
|
|
|